ARX vs LH · rev $912.9M vs P/E 23, rev $7.27B
Accelerant Holdings (ARX) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
Accelerant Holdings (ARX) is a insurance brokers company listed on NYSE.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Latest reported ARX revenue for 2025-12-31 was $912.9M. Net income was -$1.35B. Revenue was up 51.5% from 2024-12-31 to 2025-12-31. ARX currently screens at market cap $2.84B.
Latest reported LH revenue for 2026-06-30 was $7.27B. Net income was $576.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
ARX currently screens at market cap $2.84B. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the ARX and LH stock pages for the full models.
Not investment advice.